A thought-provoking phase 1 trial of pre-operative ablative breast irradiation reveals its tumoricidal effects on luminal disease is a slow biological process requiring 9–12+ months to fully manifest, challenging conventional surgical timelines and supporting delayed assessment of pathologic responses to ablative radiation writ large. | Rahimi, JAMA Netw Open 2025
